Lipid accumulation product and metabolic syndrome: A population-based study in northern Iran, Amol

Journal of Endocrinological Investigation

Volumn 39, Issue 4, 2016, Pages 375-382

  Motamed, N ^a   Razmjou, S ^b,c   Hemmasi, G ^c   Maadi, M ^c   Zamani, F ^c  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CARLETON UNIVERSITY   (Canada)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutoff point; Lipid accumulation product; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IRAN; LIPID ACCUMULATION PRODUCT INDEX; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; YOUDEN INDEX; ADOLESCENT; COHORT ANALYSIS; FOLLOW UP; LIPID METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; LIPID ACCUMULATION PRODUCT; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; RISK FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84962586309     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-015-0369-5     Document Type: Article

References (28)

1. (2006) International Diabetes Federation: the IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/metabolic-syndrome
2. Gallagher EJ, LeRoith D, Karnieli E (2011) The metabolic syndrome - from insulin resistance to obesity and diabetes. Med Clin N Am 95(5):855-873
3. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S (2013) Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol 62(8):697-703. doi: 10.1016/j.jacc.2013.05.064
4. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 287:356-359
5. Bozorgmanesh M, Hadaegh F, Azizi F (2010) Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 16(9):100
6. Bozorgmanesh M, Hadaegh F, Azizi F (2010) Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis 10(9):45
7. Yun JE, Won S, Sung J, Jee SH (2012) Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circ J 76(10):2443-2448 Epub 2012 Jul 12
8. Oladejo AO (2011) Overview of the metabolic syndrome; an emerging pandemic of public health significance. Ann Ib Postgrad Med 9(2):78-82
9. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109(4):551-556
10. Kahn HS (2005) The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 8(5):26
11. Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, Li Q (2012) Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr 66(9):1035-1038
12. Chiang JK, Koo M (2012) Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovasc Disord 24(12):78
13. Zamani F, Sohrabi M, Alipour A, Motamed N, Saeedian FS, Pirzad R, Abedi K, Maadi M, Ajdarkosh H, Hemmasi G, Khonsari M (2014) Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: a population based study. Arch Iran Med 17(11):750-754. doi:0141711/AIM.006
14. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med 23(5):469-480
15. Expert Panel on Detection, Evaluation (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486-2497
16. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640-1645
17. Taverna MJ, Martínez-Larrad MT, Frechtel GD, Serrano-Ríos M (2011) Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 164(4):559-567. doi: 10.1530/EJE-10-1039
18. Tellechea ML, Aranguren F, Martínez-Larrad MT, Serrano-Ríos M, Taverna MJ, Frechtel GD (2009) Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care 32(7):e85. doi: 10.2337/dc08-2284
19. Wakabayashi I, Daimon T (2014) A strong association between lipid accumulation product and diabetes mellitus in japanese women and men. J Atheroscler Thromb 21(3):282-288
20. Xiang S, Hua F, Chen L, Tang Y, Jiang X, Liu Z (2013) Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 121(2):115-118. doi: 10.1055/s-0032-1333261
21. Hosseinpanah F, Barzin M, Mirbolouk M, Abtahi H, Cheraghi L, Azizi F (2014) Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran lipid and glucose study. Eur J Prev Cardiol [Epub ahead of print]
22. Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, Abdul-Ghani M (2013) Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes 2013:269038. doi: 10.1155/2013/269038
23. Ghazali SM, Sanusi RA (2010) Waist circumference, waist to hip ratio, and body mass index in the diagnosis of metabolic syndrome in Nigerian subjects. Niger J Physiol Sci 25(2):187-195
24. Wang F, Wu S, Song Y, Tang X, Marshall R, Liang M, Wu Y, Qin X, Chen D, Hu Y (2009) Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr Metab Cardiovasc Dis 19(8):542-547
25. Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM (2009) Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod 24(7):1726-1731
26. Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, Li Q (2012) Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr 66(9):1035-1038
27. Wehr E, Gruber HJ, Giuliani A, Möller R, Pieber TR, Obermayer-Pietsch B (2011) The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab 96(6):E986-E990. doi: 10.1210/jc.2011-0031
28. Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F (2014) Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol (Oxf) 81(1):52-57